TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/11/25 17:00 | 2/7/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T | P | 2,209 | 2.05 | 0 | 1,078 | 49 | 3,258 | I | |||||||||||||||
2/4/25 16:45 | 1/31/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T | P.m | 2 | 2.01 | 0 | 1 | 0 | 1,795 | I | |||||||||||||||
1/31/25 17:00 | 1/29/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T | P.m | 8 | 2.01 | 0 | 4 | 0 | 1,794 | I | |||||||||||||||
1/15/25 17:00 | 1/13/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T | P.m | 34 | 2.12 | 0 | 16 | 1 | 1,790 | I | |||||||||||||||
12/27/24 21:49 | 12/26/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T | P | 192 | 2.13 | 0 | 90 | 5 | 1,774 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |